Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 308

1.

Atypical ductal hyperplasia at margin of breast biopsy--is re-excision indicated?

Arora S, Menes TS, Moung C, Nagi C, Bleiweiss I, Jaffer S.

Ann Surg Oncol. 2008 Mar;15(3):843-7. Epub 2007 Nov 7.

PMID:
17987337
2.

Optimal use of re-excision in patients diagnosed with early-stage breast cancer by excisional biopsy treated with breast-conserving therapy.

Caughran JL, Vicini FA, Kestin LL, Dekhne NS, Benitez PR, Goldstein NS.

Ann Surg Oncol. 2009 Nov;16(11):3020-7. doi: 10.1245/s10434-009-0628-9. Epub 2009 Jul 28.

PMID:
19636632
3.

The value of breast lumpectomy margin assessment as a predictor of residual tumor burden.

Wazer DE, Schmidt-Ullrich RK, Schmid CH, Ruthazer R, Kramer B, Safaii H, Graham R.

Int J Radiat Oncol Biol Phys. 1997 May 1;38(2):291-9.

PMID:
9226315
5.

Factors affecting successful breast conservation for ductal carcinoma in situ.

Dillon MF, Mc Dermott EW, O'Doherty A, Quinn CM, Hill AD, O'Higgins N.

Ann Surg Oncol. 2007 May;14(5):1618-28. Epub 2007 Feb 14.

PMID:
17443388
6.
7.
8.

Association of breast cancer with the finding of atypical ductal hyperplasia at core breast biopsy.

Moore MM, Hargett CW 3rd, Hanks JB, Fajardo LL, Harvey JA, Frierson HF Jr, Slingluff CL Jr.

Ann Surg. 1997 Jun;225(6):726-31; discussion 731-3.

9.

Multicenter evaluation of the breast lesion excision system, a percutaneous, vacuum-assisted, intact-specimen breast biopsy device.

Sie A, Bryan DC, Gaines V, Killebrew LK, Kim CH, Morrison CC, Poller WR, Romilly AP, Schilling K, Sung JH.

Cancer. 2006 Sep 1;107(5):945-9.

10.
11.

Residual disease after re-excision lumpectomy for close margins.

Sabel MS, Rogers K, Griffith K, Jagsi R, Kleer CG, Diehl KA, Breslin TM, Cimmino VM, Chang AE, Newman LA.

J Surg Oncol. 2009 Feb 1;99(2):99-103. doi: 10.1002/jso.21215.

PMID:
19065638
12.

Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins.

Dzierzanowski M, Melville KA, Barnes PJ, MacIntosh RF, Caines JS, Porter GA.

J Surg Oncol. 2005 May 1;90(2):71-6.

PMID:
15844190
13.
14.

Predicting cancer on excision of atypical ductal hyperplasia.

Doren E, Hulvat M, Norton J, Rajan P, Sarker S, Aranha G, Yao K.

Am J Surg. 2008 Mar;195(3):358-61; discussion 361-2. doi: 10.1016/j.amjsurg.2007.11.008.

PMID:
18206849
15.

The management of lobular neoplasia identified on percutaneous core breast biopsy.

Bauer VP, Ditkoff BA, Schnabel F, Brenin D, El-Tamer M, Smith S.

Breast J. 2003 Jan-Feb;9(1):4-9.

PMID:
12558663
17.

The value of breast lumpectomy margin assessment as a predictor of residual tumor burden in ductal carcinoma in situ of the breast.

Neuschatz AC, DiPetrillo T, Steinhoff M, Safaii H, Yunes M, Landa M, Chung M, Cady B, Wazer DE.

Cancer. 2002 Apr 1;94(7):1917-24.

18.

Lobular neoplasia on core-needle biopsy--clinical significance.

Arpino G, Allred DC, Mohsin SK, Weiss HL, Conrow D, Elledge RM.

Cancer. 2004 Jul 15;101(2):242-50.

19.

Intra-operative touch preparation cytology; does it have a role in re-excision lumpectomy?

Valdes EK, Boolbol SK, Cohen JM, Feldman SM.

Ann Surg Oncol. 2007 Mar;14(3):1045-50. Epub 2007 Jan 6.

PMID:
17206481
20.

Factors associated with upgrading to malignancy at surgery of atypical ductal hyperplasia diagnosed on core biopsy.

Deshaies I, Provencher L, Jacob S, Côté G, Robert J, Desbiens C, Poirier B, Hogue JC, Vachon E, Diorio C.

Breast. 2011 Feb;20(1):50-5. doi: 10.1016/j.breast.2010.06.004. Epub 2010 Jul 8.

PMID:
20619647
Items per page

Supplemental Content

Write to the Help Desk